ResearcherWestern Sydney UniversityNo recent work listed
Tianqing Liu
Matched on ORCID iD 0000-0002-9058-2643; OpenAlex author ID A5028278822. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2021: 1 paper · 2022: none · 2023: 1 paper
Papers 2
- Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer. Last author DOI 10.1016/j.ijpharm.2023.122844↗
- M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer. Last author DOI 10.3390/pharmaceutics13091493↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yongmei Zhao · 2 shared papers, 2021–2023 · strength 0.38
- Paper Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer. DOI 10.1016/j.ijpharm.2023.122844↗
- Paper M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer. DOI 10.3390/pharmaceutics13091493↗
- Yuan‐Lin Zheng · 2 shared papers, 2021–2023 · strength 0.38
- Paper Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer. DOI 10.1016/j.ijpharm.2023.122844↗
- Paper M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer. DOI 10.3390/pharmaceutics13091493↗
- Yi Zhang · 1 shared paper, 2021 · strength 0.16
- Hongyan Zhu · 1 shared paper, 2021 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.